Hamlet Biopharma Ab Is A Biotechnology Company Based In Lundswedenfocused On Developing Precision Therapies For Cancer And Infectionsfounded In 1999The Company Employs A Peptide Based Approach To Selectively Target Tumor Cells While Minimizing Harm To Healthy Tissuewith A Small Team Of Seven Employeeshamlet Biopharma Is Advancing Three Projects Currently In Phase Ii Clinical Trials The Companyae S Key Drug Candidates Include Alpha1Hwhich Shows Promise In Treating Bladder Cancerbamlettargeting Colon Cancer And Oral Malignanciesand The Hamlet Familya Novel Class Of Anti Cancer Drugs Effective Against Various Cancers With Minimal Side Effectshamlet Biopharma Aims To Address Significant Medical Needsparticularly In High Recurrence Cancers Like Bladder Cancerwhich Affects Over 614 000 Individuals Annuallyadditionallythe Company Is Exploring Alternatives To Antibiotics For Treating Infections
